Hepatitis C

Top Story

FDA approves Epclusa for pediatric HCV

March 20, 2020
In the Journals

Study confirms relevance of SVR endpoint for patients receiving HCV treatment

February 28, 2020
SVR, which has been challenged in regard to its association with clinical outcomes, has been confirmed as a prognosis-altering endpoint in patients with hepatitis C…
In the Journals

Kidneys from donors with hepatitis C virus increased recipient life expectancy, reduced costs

February 27, 2020
Transplanting kidneys from donors with hepatitis C virus into uninfected recipients reduced costs to the health care system, while also increasing life expectancy for…
In the Journals

DDIs affect around 40% of HCV patients taking DAAs

February 24, 2020
Drug-drug interactions, or DDIs, affect about 40% of patients with hepatitis C virus being treated with direct-acting antivirals, or DAAs, according to a study published…
More Headlines »
CME

HIV/AIDS 1 Hour Update For Florida Health Professionals

No commercial support for this activity.

More »
In the Journals

Patient support tool may improve treatment decisions for those with CKD, hepatitis C

January 20, 2020
For patients with both chronic kidney disease and the hepatitis C virus, an education and support tool increased…
More »
Video
Meeting News

Women on HRT, birth control safely, effectively treated HCV with Zepatier

April 14, 2018
More »